Distraction osteogenesis devices are classified as internal and external distractors based on the placement of the device. The external distractor allows bone distraction in three planes and aids surgeon to alter the direction, or vector, of the distraction process. External distractors allow for easier adjustment of the direction of the distraction. Moreover, the miniaturized internal distraction devices have made surgical procedure clinically feasible and practical, providing higher comfort to the patients.
Get Exclusive Sample Report at: https://www.coherentmarketinsights.com/insight/request-sample/1172
The factors impacting growth of the distraction osteogenesis devices market include rising number of pediatric bone defects coupled with development of novel solutions by distraction osteogenesis device manufacturers to treat facial asymmetries, mandibular hypoplasia, and other indications. Moreover, key players are focusing on research and development to introduce innovative products for enhancing patient satisfaction, procedure efficiency, and clinical outcomes, thus rising adoption of these technologically advanced devices and aiding in growth of the global distraction osteogenesis device market. For instance, in October 2017, DePuy Synthes launched MAXFRAME Multi-Axial Correction System, an external circular fixation device with a 3D planning software that helps improve accuracy of the deformity correction plan, which may reduce overall treatment time while improving procedural efficiency and reducing costs. The system is indicated for fracture fixation, limb lengthening, bone deformity correction in adults and children. However, the complications of the devices of forming marginal mandibular nerve and scars at external pin sites, requirement of second surgical procedure for removal of internal distractors, high cost of total treatment, are factors hindering growth of the distraction osteogenesis devices market.
Increasing number of pediatric bone defects is expected to aid in growth of the distraction osteogenesis devices market
Distraction osteogenesis devices aid in orthopedics, maxillofacial, and oral surgery. Distraction osteogenesis devices are used for surgical-orthodontic skeleton and asymmetries, to treat rising number of bone defect cases, and craniofacial anomalies such as cleft palate, craniosynostosis, hemifacial microsomia, and others. According to Centre for Disease Control and Prevention, 2015, about 2,650 babies are born with cleft palate and about 4,440 babies are born with cleft lip each year in the U.S. Also, according to the study by Medical Futurist, 2013, skull and bone defects, foot deformities, cleft palate account for 34% of the birth defects in the U.S., thus, leading to increasing demand for distraction osteogenesis devices in medical settings to efficiently treat facial deformities. According to the survey by Craniosynostosis and Positional Plagiocephaly Support (CAPPS) Organization, 2014, incidence of craniosynostosis is around 1 in 2,000/3,000 births, accounting for 175 infants born each day, with craniosynostosis globally.
Increasing focus on initiatives by organizations and market players to accelerate the market growth
Various initiatives by public organizations to offer effective surgical care for facial deformities globally, is expected to bolster the market growth. For instance, Operation Smile Foundation provides free surgeries for children and young adults in emerging economies such as China, India, Sub-Saharan Africa who are born with cleft lip, cleft palate or other dental and facial conditions. Operation Smiles has a global network of medical professionals providing high surgical care in over 60 countries. Also, the World Craniofacial Foundation links families of patients with medical professionals in every continent to ensure that the children with facial deformities receive high surgical and medical care.
Buy Now This Report: https://www.coherentmarketinsights.com/insight/buy-now/1172
Major players operating in the global distraction osteogenesis devices market are Johnson & Johnson, Zimmer Biomet Holdings, Inc., Stryker Corporation, KLS Martin Group, Osteomed, Acumed LLC, and Titamed.